azacitidine has been researched along with Pancytopenia in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (7.69) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 10 (76.92) | 24.3611 |
2020's | 2 (15.38) | 2.80 |
Authors | Studies |
---|---|
Itani, K; Kai, Y; Kohno, K; Kondo, Y; Matsumoto, M; Miura, G; Nakayama, T; Saburi, M; Soga, Y | 1 |
Dasanu, CA; Kaur, J; Tuler, S | 1 |
Angelopoulou, MK; Chatzidimitriou, C; Konstantopoulos, K; Korkolopoulou, P; Lafioniatis, S; Lakiotaki, E; Pappa, V; Plata, E; Vassilakopoulos, TP | 1 |
Cao, YB; DA, WM; Li, SW; Li, XH; Liu, B; Liu, ZY; Wu, XX; Wu, YM; Xu, LX; Yan, B; Yang, XL | 1 |
Chen, YH; Ding, Y; Liang, AB; Luo, X; Wu, H | 1 |
Fang, LW; Hu, NB; Li, B; Luo, XP; Pan, LJ; Qin, TJ; Qu, SQ; Xiao, ZJ; Xu, ZF; Zhang, HL; Zhang, Y | 1 |
Steensma, DP; Stone, RM | 1 |
Ahsanuddin, A; Kumar, R; Paulson, K; Seftel, MD | 1 |
Klimek, VM; Tallman, MS | 1 |
Delgado, RG; Diez Campelo, M; Molias, AC; Sanchez, JF | 1 |
Angelillo-Scherrer, A; Blum, S | 1 |
Allen, PB; Baer, MR; Kleinberg, ME; Koka, R | 1 |
Huijgens, PC; Krulder, JW; Neve, P; Wijermans, PW | 1 |
1 review(s) available for azacitidine and Pancytopenia
Article | Year |
---|---|
Practical recommendations for hypomethylating agent therapy of patients with myelodysplastic syndromes.
Topics: Aged; Antibiotic Prophylaxis; Antifungal Agents; Azacitidine; Clinical Trials as Topic; Decitabine; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Drug Administration Schedule; Enzyme Inhibitors; Epigenesis, Genetic; Fatigue; Gastrointestinal Diseases; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Injections, Subcutaneous; Mucositis; Myelodysplastic Syndromes; Pancytopenia; Patient Selection | 2010 |
12 other study(ies) available for azacitidine and Pancytopenia
Article | Year |
---|---|
[Successful treatment of myelodysplastic syndrome-associated autoinflammatory lymphedema with azacytidine].
Topics: Aged, 80 and over; Autoimmune Diseases; Azacitidine; Female; Humans; Lymphedema; Myelodysplastic Syndromes; Pancytopenia | 2019 |
Autoimmune hemolytic anemia in a patient with myelodysplastic syndrome: Responding to 5-azacitidine therapy.
Topics: Aged; Anemia, Hemolytic, Autoimmune; Autoimmune Diseases; Azacitidine; Female; Humans; Myelodysplastic Syndromes; Pancytopenia | 2021 |
Pancytopenia, eosinophilia and coagulation disorders in a patient with T-acute lymphoblastic leukemia in prolonged remission.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Biomarkers, Tumor; Blood Cell Count; Bone Marrow; Cancer Survivors; Chromosome Deletion; Chromosome Disorders; Chromosomes, Human, Pair 7; Diagnosis, Differential; Eosinophilia; Hemorrhagic Disorders; Humans; Interferon-alpha; Leukemia, Myeloid, Acute; Male; Mastocytosis, Systemic; Myelodysplastic Syndromes; Neoplasms, Second Primary; Pancytopenia; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Staurosporine; Tryptases | 2021 |
[Clinical Efficacy of Decitabine Combined with CAG Regimen for Myelodysplastic Syndrome-RAEB and Refractory Acute Myeloid Leukemia].
Topics: Aclarubicin; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Cytarabine; Decitabine; Granulocyte Colony-Stimulating Factor; Humans; Karyotype; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Pancytopenia; Recurrence; Remission Induction; Retrospective Studies; Survival Rate; Treatment Outcome | 2015 |
[Clinical Efficacy Comparison of Ultralow Dose of Decitabine and Cyclosporine on Low-risk and Intermediate-risk Type 1 of Myelodysplastic Syndrome].
Topics: Azacitidine; Cyclosporine; Decitabine; Humans; Myelodysplastic Syndromes; Pancytopenia; Retrospective Studies; Survival Rate; Treatment Outcome | 2016 |
[Analysis of the impact of decitabine treatment cycles on efficacy and safety in patients of myelodysplastic syndrome-refractory anemia with excess blasts].
Topics: Anemia, Refractory, with Excess of Blasts; Azacitidine; Blood Cell Count; China; Decitabine; Humans; Pancytopenia; Prevalence; Remission Induction; Retrospective Studies; Treatment Outcome | 2016 |
Azacytidine as a novel agent in the treatment of acute lymphoblastic leukemia.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Azacitidine; Female; Humans; Middle Aged; Pancytopenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis | 2011 |
Hypomethylating agents in acute lymphoblastic leukemia: untapped potential?
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Azacitidine; Humans; Pancytopenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis | 2011 |
Azacytidine for the treatment of myelodysplastic syndromes in the elderly.
Topics: Age Factors; Aged; Anemia, Refractory, with Excess of Blasts; Antimetabolites, Antineoplastic; Azacitidine; Blood Component Transfusion; Bone Marrow; Bone Marrow Examination; Humans; Life Expectancy; Male; Monitoring, Physiologic; Myelodysplastic Syndromes; Pancytopenia; Treatment Outcome | 2011 |
Block of red blood cell maturation in acute erythroid leukemia.
Topics: Antigens, CD; Azacitidine; Blood Cell Count; Cell Differentiation; Erythroblasts; Fatal Outcome; Humans; Leukemia, Erythroblastic, Acute; Male; Middle Aged; Pancytopenia; Polycythemia Vera; Reticulocytes | 2012 |
Scedosporium apiospermum soft tissue infection as the initial presentation of acute myeloid leukemia: a case report.
Topics: Aged, 80 and over; Amputation, Surgical; Antifungal Agents; Antimetabolites, Antineoplastic; Azacitidine; Bone Marrow; Decitabine; Diagnosis, Differential; Disease Progression; Fatal Outcome; Female; Humans; Leg Ulcer; Leukemia, Myeloid, Acute; Mycoses; Pancytopenia; Pyrimidines; Scedosporium; Soft Tissue Infections; Triazoles; Voriconazole | 2013 |
Continuous infusion of low-dose 5-Aza-2'-deoxycytidine in elderly patients with high-risk myelodysplastic syndrome.
Topics: Acute Disease; Aged; Aged, 80 and over; Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Antineoplastic Agents; Azacitidine; Decitabine; Drug Administration Schedule; Female; Humans; Leukemia, Myeloid; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Myelodysplastic Syndromes; Pancytopenia | 1997 |